Submit Manuscript Now
Current issue Archive Authors Profile
Research Articles Issue 2 · 2019 · pp. 276–280 · Issue page

STAPHYLOCOCCAL PNEUMONIA – CASE REPORT

GI
Gigi CALIN1
RA
Ramona NEDELCUTA2
CR
Cristian NEDELCUTA3
1 Department of Pediatrics, University of Medicine and Pharmacy of Craiova, Romania
2 Department of Pediatrics, University of Medicine and Pharmacy of Craiova, Romania
3 County Emergency Clinical Hospital from Craiova, Romania
Accepted 29 March 2026
Available Online 15 March 2019
Abstract
STAPHYLOCOCCAL INFECTIONS HAVE BEEN A MAJOR CONCERN OF THE CHILD'S INFECTIOUS PATHOLOGY. STAPHYLOCOCCAL PNEUMONIA, ALTHOUGH RARER THAN PNEUMOCOCCAL PNEUMONIA, REMAINS ONE OF THE CHILD'S MOST SERIOUS BACTERIAL PNEUMONIA, DESPITE THE GREAT ADVANCES OF ANTIBI OTIC THERAPY AND RESPIRATORY RESUSCITATION TECHNIQUES. STAPHYLOCOCCUS AUREUS IS THE DETERMINANT OF THE DISEASE, BUT AN IMPORTANT ROLE IS PLAYED BY A NUMBER OF FAVORABLE FACTORS: LOW AGE, PRESENCE OF NUTRITION DEFICIENCY (PREMATURITY, DYSMATURITY, PROTEIN -ENERGY MALNUTRITION), CONVULSIVE COUGH, CONGENITAL MALFORMATIONS, PREEXISTING VIRAL INFECTIONS (MEASLES, VARICELLA) PROLONGED ANTIBIOTIC THERAPY, DIABETES MELLITUS, IMMUNE DEFICIENCIES, CYSTIC FIBROSIS, BRONCHIECTASIS, ETC.
Keywords
STAPHYLOCOCCUS PNEUMONIA CHILD
Full Text
The body of this article is intentionally hidden on the public page. Please use the PDF reader or the PDF download for the complete text.
References
[1]
DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. 2010. Communityassociated meticillin -resistant Staphylococcus aureus. Lancet 375: 1557–1568. https://doi.org/10.1016/S0140-6736(09)61999-1.
[2]
Vandijck DM, Annemans L, Vogelaers DP, Blot SI. 2009. Hospital costs in patients with nosocomial methicillin-resistant or methicillin -susceptible Staphylococcus aureus bloodstream infection. Infect Control Hosp Epidemiol 30:1127–1128. https://doi.org/10.1086/647984.
[3]
Greiner W, Rasch A, Kohler D, Salzberger B, Fatkenheuer G, Leidi g M. 2007. Clinical outcome and costs of nosocomial and communityacquired Staphylococcus aureus bloodstream infection in haemodialysis patients. Clin Microbiol Infect 13:264 –268. https://doi.org/10.1111/j.1469 - 0691.2006.01622.x.
[4]
Lowy FD . 1998. Staphylococ cus aureus infections. N Engl J Med 339: 520 –532. https://doi.org/10.1056/NEJM199808203390806.
[5]
Mistry RD. 2013. Skin and soft tissue infections. Pediatr Clin North Am 60:1063 –1082. https://doi.org/10.1016/j.pcl.2013.06.011.
[6]
Rodriguez M, Hogan PG, Burnham CA, Fritz SA. 2014. Molecular epidemiology of Staphylococcus aureus in households of children with community -associated S aureus skin and soft tissue inf ections. J Pediatr 164:105–111. https://doi.org/10.1016/j.jpeds.2013.08.072.
[7]
Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK . 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298: 1763–1771. https://doi.org/10.1001/jama.298.15.1763.
[8]
Naber CK. 2009. Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies. Clin Infect Dis 48: S231–S237. https://doi.org/10.1086/598189.
[9]
Kluytmans J, van Belkum A, Verbrugh H. 1997. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10:505 –520.
[10]
Safdar N, Bradley EA. 2008. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 121:310 –315. https://doi.org/10 .1016/j.amjmed.2007.07.034.
[11]
von Eiff C, Becker K, Machka K, Stammer H, Peters G . 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 344: 11 –16. https://doi.org/10.1056/NEJM200101043440102.
[12]
Toshkova K, Annemuller C, Akineden O, Lammler C . 2001. The significance of nasal carriage of Staphylococcus aureus as risk factor for human skin infections. FEMS Microbiol Lett 202:17 –24. https://doi.org/10.1111/ j.1574-6968.2001.tb10774.x.
[13]
Lee AS, de Lencastre H, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A, Harbarth S. 2018. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers 4:18033. https://doi.org/10.1038/nrdp.2018.33.
[14]
McGuinness WA, Malachowa N, DeLeo FR. 2017. Vancomycin resistance in Staphylococcus aureus. Yale J Biol Med 90:269 –281.
[15]
Ghahremani M, Jazani NH, Sharifi Y . 2018. Emergence of vancomycinintermediate and -resistant Staphylococcus aureus among methicillinresistant S. aureus isolated from clinical specimens in the northwest of Iran. J Glob